Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
4.920
+0.070 (1.44%)
Nov 22, 2024, 4:00 PM EST - Market closed

Tenax Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
--7.71-11.05-32.47-9.85-8.39
Upgrade
Depreciation & Amortization
-0.010.110.110.110.11
Upgrade
Loss (Gain) From Sale of Assets
-0-0--0
Upgrade
Loss (Gain) From Sale of Investments
---0.010.01-0
Upgrade
Stock-Based Compensation
-0.190.370.770.350.27
Upgrade
Other Operating Activities
-0.02021.340-
Upgrade
Change in Accounts Receivable
--0.31-0.36-0.020.7-0.32
Upgrade
Change in Accounts Payable
-1.89-0.34-0.54-0.540.88
Upgrade
Change in Other Net Operating Assets
---0.12-0.04-0.06-0.1
Upgrade
Operating Cash Flow
--5.9-11.39-10.86-9.27-7.56
Upgrade
Capital Expenditures
---0-0.01-0-0
Upgrade
Sale of Property, Plant & Equipment
-0----
Upgrade
Investment in Securities
---0.460.020
Upgrade
Investing Cash Flow
-0-00.450.02-0
Upgrade
Long-Term Debt Issued
----0.24-
Upgrade
Total Debt Issued
----0.24-
Upgrade
Short-Term Debt Repaid
--0.62----
Upgrade
Total Debt Repaid
--0.62----
Upgrade
Net Debt Issued (Repaid)
--0.62--0.24-
Upgrade
Issuance of Common Stock
-000.5410.350.1
Upgrade
Other Financing Activities
-14.197.939.19--
Upgrade
Financing Cash Flow
-13.577.939.7410.60.1
Upgrade
Net Cash Flow
-7.67-3.46-0.671.34-7.46
Upgrade
Free Cash Flow
--5.9-11.39-10.86-9.28-7.56
Upgrade
Free Cash Flow Per Share
--23.76-619.37-844.53--
Upgrade
Levered Free Cash Flow
--3.79-7.77-19.33-5.49-4.44
Upgrade
Unlevered Free Cash Flow
--3.77-7.76-19.33-5.49-4.44
Upgrade
Change in Net Working Capital
-1.4-1.171.330.5-0.22-0.53
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.